LEADER 02083oam  2200505Ia 450 
001 9910701867603321
005 20120530154821.0
035   $a(CKB)5470000002421430
035   $a(OCoLC)794523587
035   $a(EXLCZ)995470000002421430
100   $a20120530d1977      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBioassay of phenformin for possible carcinogenicity$b[electronic resource] /$fCarcinogen Bioassay and Program Resources Branch, Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute ; [prepared at Tracor Jitco under the direction of J.F. Robens, with the assistance of G.L. Miller and L.A. Waitz]
210  1$aWashington, D.C. :$cU.S. Dept. of Health, Education and Welfare, Public Health Service, National Institutes of Health,$d1977.
215   $a1 online resource (ix, 90 pages) $cillustrations
225 1 $aDHEW publication ; no. (NIH) 77-807
225 1 $aCarcinogenesis technical report series ;$vno. 7
300   $aTitle from title screen (viewed on May 30, 2012).
300   $a"The Chemical Abstracts Service (CAS) Registry Number used to track this bioassay is 834-28-6, which is determined to best define the material used in the conduct of this bioassay."
300   $a"CAS No. 114-86-3."
300   $a"NCI-CG-TR-7."
320   $aIncludes bibliographical references (page 47).
606   $aHypoglycemic agents
606   $aDiabetes
606   $aCarcinogenesis
606   $aCarcinogens
615  0$aHypoglycemic agents.
615  0$aDiabetes.
615  0$aCarcinogenesis.
615  0$aCarcinogens.
701   $aMiller$b G. L$01397232
701   $aWaitz$b L. A$01397233
701   $aRobens$b J. F$01397234
712 02$aNational Institutes of Health (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910701867603321
996   $aBioassay of phenformin for possible carcinogenicity$93458655
997   $aUNINA